Co-Founder And Managing Partner
CurrentAllosteRx Capital is an early-stage life science VC targeting advanced therapies including cell and gene therapy, and genetically targeted therapies. Together with AllosteRx Capital Managing Director Dr. Cynthia Lavoie, we are currently raising Fund I. We have forged a one-of-a-kind strategic partnership with the Center for Commercialization of Regenerative Medicine (CCRM), a cell and gene therapy CDMO. A warehouse of potential portfolio companies, including from CCRM, is anticipated to fuel portfolio development.